biomedcentral.com/content
Bottom,Top,Right1
  • Welcome Roswell Park Cancer Inst
  • Log on
  • biomed central
  • chemistry central
  • SpringerOpen
BioMed Central
Advanced search
  • Home
  • Journals
  • Articles
  • Gateways
  • About BioMed Central
  • My BioMed Central

Submit a manuscript Register Sign up for article alerts Contact us

Institution search

Search by institution name/city

Members

  • Australia (21)
  • Austria (6)
  • Belgium (3)
  • Brazil (3)
  • Burkina Faso (1)
  • Canada (27)
  • Central African Republic (1)
  • China (3)
  • Cyprus (3)
  • Czech Republic (1)
  • Denmark (1)
  • Ethiopia (1)
  • Finland (6)
  • France (7)
  • Germany (51)
  • Ghana (3)
  • Greece (1)
  • Hong Kong (2)
  • Hungary (1)
  • India (7)
  • Ireland (1)
  • Israel (1)
  • Italy (14)
  • Kenya (3)
  • Korea, South (2)
  • Lebanon (1)
  • Lithuania (1)
  • Luxembourg (1)
  • Madagascar (1)
  • Malaysia (3)
  • Mexico (1)
  • Morocco (2)
  • Netherlands (10)
  • New Zealand (1)
  • Nigeria (2)
  • Norway (4)
  • Poland (2)
  • Portugal (1)
  • Romania (1)
  • South Africa (6)
  • Spain (14)
  • Sweden (9)
  • Switzerland (10)
  • Taiwan (3)
  • Tanzania (2)
  • Thailand (1)
  • Trinidad and Tobago (1)
  • Turkey (1)
  • Uganda (1)
  • United Kingdom (49)
  • United States of America (157)

Advertisement

Supporter Member - Roswell Park Cancer Inst


Research staff and students at Roswell Park Cancer Inst:

Do you realize that you will get a 15% discount on the article-processing charges of all research articles accepted for publication in journals published by BioMed Central ? Read more information about publishing your articles with us.



Work published with BioMed Central, Chemistry Central and SpringerOpen by researchers at Roswell Park Cancer Inst

  • Latest RSS
  • Most viewed
    • Last 30 days
    • Last year

Page 2 of 2

 Previous 1 2

 Display/download options Articles per page: 25 | 50 | 100

Display options
Download optionsHelp icon

26.

Research article   Open Access Highly Accessed

Novel genetic variants in miR-191 gene and familial ovarian cancer

Jie Shen, Richard DiCioccio, Kunle Odunsi, Shashikant B Lele, Hua Zhao BMC Cancer 2010, 10:47 (18 February 2010)

Abstract | Full text | PDF | PubMed

27.

Research   Open Access Highly Accessed

Cancer cell sensitivity to bortezomib is associated with survivin expression and p53 status but not cancer cell types

Xiang Ling, Diane Calinski, Asher A Chanan-Khan, Muxiang Zhou, Fengzhi Li Journal of Experimental & Clinical Cancer Research 2010, 29:8 (22 January 2010)

Abstract | Full text | PDF | PubMed

28.

Research article   Open Access

Par-3 partitioning defective 3 homolog (C. elegans) and androgen-induced prostate proliferative shutoff associated protein genes are mutationally inactivated in prostate cancer cells

Dimiter Kunnev, Igor Ivanov, Yurij Ionov BMC Cancer 2009, 9:318 (8 September 2009)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Page 2 of 2

 Previous 1 2


  • Terms and Conditions
  • Cookies
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.